Thanks Hodgie, head and neck cancer is hard going mate.....Probably the most likely of cancers
to be given the fast track status.....It seems Immutep had prepared themselves for possible fast
track acceptance from it's Aipac trials...Unfortunately that hasn't eventuated at this stage but at least
they've done the exercise and know what's entailed......
Couple of things.....Aipac is a combo with a generic drug as efti's sidekick...
Tacti-002 is with keytruda, a drug still under patent...
Just my opinion but given the complexities and difficulties associated with head and neck cancer
I don't think trial results will have to be spectactular to get due consideration into fast track status..
For those interested...Head and Neck Cancers - National Cancer Institute
ESMO, page-3
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.040(11.0%) |
Mkt cap ! $588.3M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 40.5¢ | 36.8¢ | $1.822M | 4.681M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19739 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 45420 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |